BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 19858458)

  • 1. "Frontotemporoparietal" dementia: clinical phenotype associated with the c.709-1G>A PGRN mutation.
    Moreno F; Indakoetxea B; Barandiaran M; Alzualde A; Gabilondo A; Estanga A; Ruiz J; Ruibal M; Bergareche A; Martí-Massó JF; López de Munain A
    Neurology; 2009 Oct; 73(17):1367-74. PubMed ID: 19858458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotype variability in progranulin mutation carriers: a clinical, neuropsychological, imaging and genetic study.
    Le Ber I; Camuzat A; Hannequin D; Pasquier F; Guedj E; Rovelet-Lecrux A; Hahn-Barma V; van der Zee J; Clot F; Bakchine S; Puel M; Ghanim M; Lacomblez L; Mikol J; Deramecourt V; Lejeune P; de la Sayette V; Belliard S; Vercelletto M; Meyrignac C; Van Broeckhoven C; Lambert JC; Verpillat P; Campion D; Habert MO; Dubois B; Brice A;
    Brain; 2008 Mar; 131(Pt 3):732-46. PubMed ID: 18245784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropathologic features of frontotemporal lobar degeneration with ubiquitin-positive inclusions with progranulin gene (PGRN) mutations.
    Josephs KA; Ahmed Z; Katsuse O; Parisi JF; Boeve BF; Knopman DS; Petersen RC; Davies P; Duara R; Graff-Radford NR; Uitti RJ; Rademakers R; Adamson J; Baker M; Hutton ML; Dickson DW
    J Neuropathol Exp Neurol; 2007 Feb; 66(2):142-51. PubMed ID: 17278999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progranulin Leu271LeufsX10 is one of the most common FTLD and CBS associated mutations worldwide.
    Benussi L; Ghidoni R; Pegoiani E; Moretti DV; Zanetti O; Binetti G
    Neurobiol Dis; 2009 Mar; 33(3):379-85. PubMed ID: 19101631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum progranulin levels in patients with frontotemporal lobar degeneration and Alzheimer's disease: detection of GRN mutations in a Spanish cohort.
    Antonell A; Gil S; Sánchez-Valle R; Balasa M; Bosch B; Prat MC; Chiollaz AC; Fernández M; Yagüe J; Molinuevo JL; Lladó A
    J Alzheimers Dis; 2012; 31(3):581-91. PubMed ID: 22647257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropathologic heterogeneity in HDDD1: a familial frontotemporal lobar degeneration with ubiquitin-positive inclusions and progranulin mutation.
    Behrens MI; Mukherjee O; Tu PH; Liscic RM; Grinberg LT; Carter D; Paulsmeyer K; Taylor-Reinwald L; Gitcho M; Norton JB; Chakraverty S; Goate AM; Morris JC; Cairns NJ
    Alzheimer Dis Assoc Disord; 2007; 21(1):1-7. PubMed ID: 17334266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Founder effect and estimation of the age of the Progranulin Thr272fs mutation in 14 Italian pedigrees with frontotemporal lobar degeneration.
    Borroni B; Bonvicini C; Galimberti D; Tremolizzo L; Papetti A; Archetti S; Turla M; Alberici A; Agosti C; Premi E; Appollonio I; Rainero I; Ferrarese C; Gennarelli M; Scarpini E; Padovani A
    Neurobiol Aging; 2011 Mar; 32(3):555.e1-8. PubMed ID: 20947212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deletion of the progranulin gene in patients with frontotemporal lobar degeneration or Parkinson disease.
    Rovelet-Lecrux A; Deramecourt V; Legallic S; Maurage CA; Le Ber I; Brice A; Lambert JC; Frébourg T; Hannequin D; Pasquier F; Campion D
    Neurobiol Dis; 2008 Jul; 31(1):41-5. PubMed ID: 18479928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progranulin null mutations in both sporadic and familial frontotemporal dementia.
    Le Ber I; van der Zee J; Hannequin D; Gijselinck I; Campion D; Puel M; Laquerrière A; De Pooter T; Camuzat A; Van den Broeck M; Dubois B; Sellal F; Lacomblez L; Vercelletto M; Thomas-Antérion C; Michel BF; Golfier V; Didic M; Salachas F; Duyckaerts C; Cruts M; Verpillat P; Van Broeckhoven C; Brice A;
    Hum Mutat; 2007 Sep; 28(9):846-55. PubMed ID: 17436289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alzheimer and Parkinson diagnoses in progranulin null mutation carriers in an extended founder family.
    Brouwers N; Nuytemans K; van der Zee J; Gijselinck I; Engelborghs S; Theuns J; Kumar-Singh S; Pickut BA; Pals P; Dermaut B; Bogaerts V; De Pooter T; Serneels S; Van den Broeck M; Cuijt I; Mattheijssens M; Peeters K; Sciot R; Martin JJ; Cras P; Santens P; Vandenberghe R; De Deyn PP; Cruts M; Van Broeckhoven C; Sleegers K
    Arch Neurol; 2007 Oct; 64(10):1436-46. PubMed ID: 17923627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical diagnosis of early-onset dementias: diagnostic accuracy and clinicopathological relationships.
    Snowden JS; Thompson JC; Stopford CL; Richardson AM; Gerhard A; Neary D; Mann DM
    Brain; 2011 Sep; 134(Pt 9):2478-92. PubMed ID: 21840888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progranulin locus deletion in frontotemporal dementia.
    Gijselinck I; van der Zee J; Engelborghs S; Goossens D; Peeters K; Mattheijssens M; Corsmit E; Del-Favero J; De Deyn PP; Van Broeckhoven C; Cruts M
    Hum Mutat; 2008 Jan; 29(1):53-8. PubMed ID: 18157829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progranulin: normal function and role in neurodegeneration.
    Eriksen JL; Mackenzie IR
    J Neurochem; 2008 Jan; 104(2):287-97. PubMed ID: 17953663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of progranulin function in frontotemporal lobar degeneration.
    Cruts M; Van Broeckhoven C
    Trends Genet; 2008 Apr; 24(4):186-94. PubMed ID: 18328591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum biomarker for progranulin-associated frontotemporal lobar degeneration.
    Sleegers K; Brouwers N; Van Damme P; Engelborghs S; Gijselinck I; van der Zee J; Peeters K; Mattheijssens M; Cruts M; Vandenberghe R; De Deyn PP; Robberecht W; Van Broeckhoven C
    Ann Neurol; 2009 May; 65(5):603-9. PubMed ID: 19288468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21.
    Cruts M; Gijselinck I; van der Zee J; Engelborghs S; Wils H; Pirici D; Rademakers R; Vandenberghe R; Dermaut B; Martin JJ; van Duijn C; Peeters K; Sciot R; Santens P; De Pooter T; Mattheijssens M; Van den Broeck M; Cuijt I; Vennekens K; De Deyn PP; Kumar-Singh S; Van Broeckhoven C
    Nature; 2006 Aug; 442(7105):920-4. PubMed ID: 16862115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low plasma progranulin levels predict progranulin mutations in frontotemporal lobar degeneration.
    Ghidoni R; Benussi L; Glionna M; Franzoni M; Binetti G
    Neurology; 2008 Oct; 71(16):1235-9. PubMed ID: 18768919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sporadic and familial dementia with ubiquitin-positive tau-negative inclusions: clinical features of one histopathological abnormality underlying frontotemporal lobar degeneration.
    Godbolt AK; Josephs KA; Revesz T; Warrington EK; Lantos P; King A; Fox NC; Al Sarraj S; Holton J; Cipolotti L; Khan MN; Rossor MN
    Arch Neurol; 2005 Jul; 62(7):1097-101. PubMed ID: 16009765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic variability in progranulin contributes to risk for clinically diagnosed Alzheimer disease.
    Brouwers N; Sleegers K; Engelborghs S; Maurer-Stroh S; Gijselinck I; van der Zee J; Pickut BA; Van den Broeck M; Mattheijssens M; Peeters K; Schymkowitz J; Rousseau F; Martin JJ; Cruts M; De Deyn PP; Van Broeckhoven C
    Neurology; 2008 Aug; 71(9):656-64. PubMed ID: 18565828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations other than null mutations producing a pathogenic loss of progranulin in frontotemporal dementia.
    van der Zee J; Le Ber I; Maurer-Stroh S; Engelborghs S; Gijselinck I; Camuzat A; Brouwers N; Vandenberghe R; Sleegers K; Hannequin D; Dermaut B; Schymkowitz J; Campion D; Santens P; Martin JJ; Lacomblez L; De Pooter T; Peeters K; Mattheijssens M; Vercelletto M; Van den Broeck M; Cruts M; De Deyn PP; Rousseau F; Brice A; Van Broeckhoven C
    Hum Mutat; 2007 Apr; 28(4):416. PubMed ID: 17345602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.